Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Clinical trial NCT03535961 · COMPLETED
Trial details
- NCT number
- NCT03535961
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2019-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.